These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19337883)

  • 41. ADD and soft signs.
    Foodman A; McPhillips K
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):841-2. PubMed ID: 8768341
    [No Abstract]   [Full Text] [Related]  

  • 42. Putamen lesions and the development of attention-deficit/hyperactivity symptomatology.
    Max JE; Fox PT; Lancaster JL; Kochunov P; Mathews K; Manes FF; Robertson BA; Arndt S; Robin DA; Lansing AE
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):563-71. PubMed ID: 12014789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emotional task-dependent low-frequency fluctuations and methylphenidate: Wavelet scaling analysis of 1/f-type fluctuations in fMRI of the cerebellar vermis.
    Anderson CM; Lowen SB; Renshaw PF
    J Neurosci Methods; 2006 Feb; 151(1):52-61. PubMed ID: 16427128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
    Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
    Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD.
    Anderson CM; Polcari A; Lowen SB; Renshaw PF; Teicher MH
    Am J Psychiatry; 2002 Aug; 159(8):1322-8. PubMed ID: 12153824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [EEG diagnosis before beginning and during drug treatment of hyperkinetic children and adolescents].
    Gabriel KH
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):231-2; author reply 233-4. PubMed ID: 12942795
    [No Abstract]   [Full Text] [Related]  

  • 48. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate.
    Moll GH; Heinrich H; Trott G; Wirth S; Rothenberger A
    Neurosci Lett; 2000 Apr; 284(1-2):121-5. PubMed ID: 10771177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Emotional regulation and motivation in children with ADHD].
    Høvik MF; Plessen KJ
    Tidsskr Nor Laegeforen; 2010 Dec; 130(23):2349-52. PubMed ID: 21139659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder.
    Pitzianti M; D'Agati E; Casarelli L; Pontis M; Kaunzinger I; Lange KW; Tucha O; Curatolo P; Pasini A
    Cogn Neuropsychiatry; 2016 Nov; 21(6):475-493. PubMed ID: 27690748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate.
    Rubia K; Halari R; Christakou A; Taylor E
    Philos Trans R Soc Lond B Biol Sci; 2009 Jul; 364(1525):1919-31. PubMed ID: 19487194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Examination of neurological subtle signs in ADHD as a clinical tool for the diagnosis and their relationship to spatial working memory.
    Ferrin M; Vance A
    J Child Psychol Psychiatry; 2012 Apr; 53(4):390-400. PubMed ID: 22141455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered neural substrates of cognitive control in childhood ADHD: evidence from functional magnetic resonance imaging.
    Vaidya CJ; Bunge SA; Dudukovic NM; Zalecki CA; Elliott GR; Gabrieli JD
    Am J Psychiatry; 2005 Sep; 162(9):1605-13. PubMed ID: 16135618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuronal network models of ADHD -- lateralization with respect to interhemispheric connectivity reconsidered.
    Roessner V; Banaschewski T; Uebel H; Becker A; Rothenberger A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I71-9. PubMed ID: 15322958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward a pathophysiology of attention-deficit/hyperactivity disorder.
    Castellanos FX
    Clin Pediatr (Phila); 1997 Jul; 36(7):381-93. PubMed ID: 9241475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential pathomechanisms of ADHD based on neurometabolite changes.
    Husarova V; Ondrejka I; Tonhajzerova I
    Neuro Endocrinol Lett; 2010; 31(4):438-45. PubMed ID: 20802444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The shape of things to come in attention deficit hyperactivity disorder.
    Shaw P
    Am J Psychiatry; 2010 Apr; 167(4):363-5. PubMed ID: 20360322
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder.
    Malone MA; Kershner JR; Swanson JM
    J Child Neurol; 1994 Apr; 9(2):181-9. PubMed ID: 8006372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention-Deficit/Hyperactivity Disorder.
    Bokor G; Anderson PD
    J Pharm Pract; 2014 Aug; 27(4):336-49. PubMed ID: 25092688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Syndrome of attention deficit with hyperactivity as the expression of an organic functional disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2002 Jul 1-15; 35(1):1-11. PubMed ID: 12389185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.